SHABEEB, Z. A.; FARAJ, Y. F.; MTASHAR, B. A.; HUSSEIN, M. S.; HASAN, A. F. Immune-biomarker signature predicts early molecular response in Iraqi chronic myeloid leukemia patients receiving front-line tyrosine-kinase inhibitors. Regulatory Mechanisms in Biosystems, v. 16, n. 4, p. e25197, 2 Dec. 2025.